| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Wei Ren CEO | SSE Exchange | CNE000001CM5 ISIN |
| CN Country | 4,142 Employees | 15 Jun 2026 Last Dividend | 28 May 2010 Last Split | 11 Sep 2002 IPO Date |
Yabao Pharmaceutical Group Co., Ltd is a renowned entity in the pharmaceutical sector, emphasizing on the research, development, manufacturing, and distribution of both traditional Chinese and Western medicinal products along with pharmaceutical packaging materials. Its operations are widespread, encompassing both domestic (China) and international markets. Established in 1978, Yabao Pharmaceutical has carved a niche for itself in the healthcare industry and is headquartered in Yuncheng, China. Its commitment to advancing healthcare solutions has positioned it as a key player in the pharmaceutical landscape.
Yabao Pharmaceutical offers a comprehensive range of medicines specifically designed for children, addressing various health conditions in this sensitive demographic.
Specializing in the development and manufacturing of products targeting cardiovascular and cerebrovascular diseases, Yabao Pharmaceutical provides effective treatments for some of the most common and debilitating health issues.
With a focus on endocrine disorders, Yabao Pharmaceutical develops treatments that help manage and treat conditions related to hormone imbalances and disturbances in the endocrine system.
Dedicated to improving women's health, Yabao offers an array of products that cater to the unique health needs and challenges faced by women.
Yabao Pharmaceutical extends its product line to include therapeutic patches, providing innovative and convenient treatment methods for a variety of conditions.
Apart from specializing in specific healthcare areas, Yabao Pharmaceutical also produces a wide range of general health products aimed at maintaining and improving overall health and well-being.